Online customer service
Customer service hotline
Customer service team:
在线客服
Skype
Wangwang:
QQ:
Service time:
8:00 - 17:00

National Advisory Hotline

400-8536-777

Add: No. 17, Tianjin North Road, Yantai Development Zone

Copyright © 2020 Yantai Huaxin Biomedical Science and Technology Co., Ltd

Lu ICP No.14008762 Powered by 300.cn

Huaxin Biomedical

WeChat

Huaxin Biomedical

Mobile official website

Yantai Huaxin Biomedical Science and Technology Co., Ltd

>
>
>
Chairman of Chifeng Wanze Pharmaceutical Company visited Huaxin Biology for investigation and cooperation

Chairman of Chifeng Wanze Pharmaceutical Company visited Huaxin Biology for investigation and cooperation

Page view
[Abstract]:
On the morning of February 25th, Wang Yuan, chairman of "Chifeng Wanze Pharmaceutical Co., Ltd." and his party visited our company. The chairman of Huaxin Biotechnology Li Lelin and the company's senior leaders warmly approached and expressed his appreciation to the arrival of Chairman Wang Yuan and his party. A warm welcome.

On the morning of February 25th, Wang Yuan, chairman of "Chifeng Wanze Pharmaceutical Co., Ltd." and his party visited our company. The chairman of Huaxin Biotechnology Li Lelin and the company's senior leaders warmly approached and expressed his appreciation to the arrival of Chairman Wang Yuan and his party. A warm welcome.

 

 

 

Chifeng Wanze Pharmaceutical Co., Ltd. is a comprehensive high-tech pharmaceutical enterprise integrating scientific research and development, production of raw materials, preparations, food, cosmetics, domestic marketing, and international trade; it has chemical raw materials, tablets, and capsules. There are 85 varieties of eight types of dosage forms, including granules, ointments, creams, solutions, and liniments. Among them, there are 7 varieties of raw materials (tosufloxacin tosylate, sodium alginate, nitrendipine, Cimetidine, nicotinic acid Xantinol, aspirin zinc, tripibuton), 78 varieties of preparations; formed the national second-class new drug tosufloxacin tosylate raw materials and preparations, national patent varieties of traditional Chinese medicine preparations ginseng Ointment, pharmaceutical intermediate 3-aminopyrrolidine dihydrochloride and other series products.

In the afternoon, Chairman Wang Yuan and his party, accompanied by Chairman Li Lelin and the company’s senior management, visited the GMP standard workshop and R&D center of Huaxin Biotech. Chairman Wang Yuan recognized Huaxin Biotech’s international advanced equipment and expressed The large investment in research and development is highly appreciated.

 

 

 

Afterwards, the two parties came to the meeting room to have in-depth discussions on deepening cooperation and achieving a win-win development direction. At the meeting, Chairman Wang Yuan said: Shenji Ointment is an OTC (National Medicine Standard B20020541) product of Wanze Pharmaceutical and has a national invention. Patent, it has significant effect on removing chloasma and improving complexion. You must choose a company with strict product quality control, mature production technology, and perfect sales team for cooperation and transformation. Huaxin Bio is just such a mature skin care product. R&D, production and sales enterprises, this will also be an important part of the in-depth cooperation with Huaxin Biotechnology in the future.

 

 

Chairman Li Lelin said: Huaxin Biotech attaches great importance to this negotiation. Wanze Pharmaceutical is a drug research and development and production enterprise. The Shenji ointment product has a good effect. Huaxin Bio has advanced equipment and biological efficacy. With the mature research and development technology of skin care products, we will highly combine the functional ingredients of ginseng ointment with skin care products. This will be another "weapon" to open up market segments. The two parties will establish a continuous and stable relationship in future cooperation. , Seek mutual benefit and seek long-term development together!

 

Classification summary:
企业新闻
Huaxin Bio-Zhonglianhe International & Yanxuan Aishanmei project kick-off meeting was successfully held
2021-03-05
On the morning of March 4, 2021, the launch meeting of Huaxin Bio·Zhonglianhe International & Yanxuan Aishanmei Project was successfully held in Yantai Huaxin Biomedical Technology Co., Ltd.; the project kick-off meeting was Huaxin Bio&Zhonglian And the first appearance promotion of the international "Goose Selection APP".
Han Zhihui, President of Guanghua Bosite, and his working group came to Huaxin Bio to visit and exchange
2021-03-03
On the morning of March 2, Han Zhihui, President of Guanghua BST, together with the expert group Zhu Yanhui and Yu Runjie, visited Yantai Huaxin Bio-Pharmaceutical Technology Co., Ltd., and Li Lelin, Chairman of Huaxin Bio-Pharmaceutical, warmly received with the company’s high-level executives. Mr. Han Zhihui One party introduced the company's development history and vision in detail.
Chairman of Chifeng Wanze Pharmaceutical Company visited Huaxin Biology for investigation and cooperation
2021-06-18
On the morning of February 25th, Wang Yuan, chairman of "Chifeng Wanze Pharmaceutical Co., Ltd." and his party visited our company. The chairman of Huaxin Biotechnology Li Lelin and the company's senior leaders warmly approached and expressed his appreciation to the arrival of Chairman Wang Yuan and his party. A warm welcome.
"Miss Taohui" 100 echelon elites come to Huaxin to select domestic products!
2020-12-09
Following the "Miss Taohui" announcement on November 22nd, Chairman Youming led the company's high-level officials to visit Huaxin Biopharmaceuticals, and recognized the high standards, high quality, and high-tech products of Huaxin Biopharmaceuticals. On December 8th, Chairman Jie took charge again! Lead a hundred echelon elites to come to Huaxin to select good products, seek cooperation and seek development!
Our company participated in the Boao Forum for Asia Global Health Expo
2019-06-19
On June 10-12, the first Boao Forum for Asia Global Health Forum was held in China Railway Qingdao World Expo City, West Coast New District, Qingdao City, Shandong Province.
Our company was approved by Yantai City
2019-04-17
Recently, the Yantai Municipal Science and Technology Bureau announced the proposed project of the Yantai Key Research and Development Plan in 2019. The project "Research on the Effective Material Basis and Mechanism of the Classic Chinese Medicine Gentiana against Rheumatoid Arthritis" jointly declared by Yantai University and our company was approved. As a key research and development plan, the project number is "2019XDHZ109". The project is led by Yantai University.